scispace - formally typeset
Journal ArticleDOI

Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism

Reads0
Chats0
TLDR
Mutations in the newly identified gene appear to be responsible for the pathogenesis of Autosomal recessive juvenile parkinsonism, and the protein product is named ‘Parkin’.
Abstract
Parkinson's disease is a common neurodegenerative disease with complex clinical features1. Autosomal recessive juvenile parkinsonism (AR-JP)2,3 maps to the long arm of chromosome 6 (6q25.2-q27) and is linked strongly to the markers D6S305 and D6S253 (ref. 4); the former is deleted in one Japanese AR-JP patient5. By positional cloning within this microdeletion, we have now isolated a complementary DNA clone of 2,960 base pairs with a 1,395-base-pair open reading frame, encoding a protein of 465 amino acids with moderate similarity to ubiquitin at the amino terminus and a RING-finger motif at the carboxy terminus. The gene spans more than 500 kilobases and has 12 exons, five of which (exons 3–7) are deleted in the patient. Four other AR-JP patients from three unrelated families have a deletion affecting exon 4 alone. A 4.5-kilobase transcript that is expressed in many human tissues but is abundant in the brain, including the substantia nigra, is shorter in brain tissue from one of the groups of exon-4-deleted patients. Mutations in the newly identified gene appear to be responsible for the pathogenesis of AR-JP, and we have therefore named the protein product ‘Parkin’.

read more

Citations
More filters
Journal ArticleDOI

The genetics and neuropathology of Parkinson's disease.

TL;DR: The genetic, clinical and pathological findings of autosomal dominant disease linked to mutations in SNCA, LRRK2, ATXN2,ATXN3, MAPT, GCH1, DCTN1 and VPS35 are summarized.
Journal ArticleDOI

Autophagy in acute kidney injury.

TL;DR: In models of AKI, autophagy deletion in proximal tubules worsened tubular injury and renal function, highlighting thatAutophagy is renoprotective in models ofAKI and pose potentially unique targets for therapeutic interventions in AKI.
Journal ArticleDOI

Trehalose ameliorates dopaminergic and tau pathology in parkin deleted/tau overexpressing mice through autophagy activation.

TL;DR: This study develops and characterized a mouse model of tauopathy with parkinsonism, overexpressing human mutated tau protein with deletion of parkin, and opens the way for clinical studies of the effects of trehalose in human tauopathies.
Journal ArticleDOI

Oxidative damage to macromolecules in human Parkinson disease and the rotenone model.

TL;DR: The recent evidence for oxidative damage to nucleic acids, lipids, and proteins in both the brain and the peripheral tissues in human PD and in the rotenone model is reviewed.
PatentDOI

A susceptibility gene for late-onset idiopathic parkinson's disease

TL;DR: In this paper, Park8 therapeutic agents, including the PARK8 nucleic acids, Park8 polypeptides, or agents that alter the activity of an PARK8polypeptide, as well as pharmaceutical compositions comprising the PARK 8 therapeutic agents are disclosed.
References
More filters
Book

Molecular Cloning: A Laboratory Manual

TL;DR: Molecular Cloning has served as the foundation of technical expertise in labs worldwide for 30 years as mentioned in this paper and has been so popular, or so influential, that no other manual has been more widely used and influential.
Journal ArticleDOI

Mutation in the α-synuclein gene identified in families with Parkinson's disease

TL;DR: A mutation was identified in the α-synuclein gene, which codes for a presynaptic protein thought to be involved in neuronal plasticity, in the Italian kindred and in three unrelated families of Greek origin with autosomal dominant inheritance for the PD phenotype.
Journal ArticleDOI

Alpha-synuclein in Lewy bodies.

TL;DR: Strong staining of Lewy bodies from idiopathic Parkinson's disease with antibodies for α-synuclein, a presynaptic protein of unknown function which is mutated in some familial cases of the disease, indicates that the LewY bodies from these two diseases may have identical compositions.
Journal ArticleDOI

Mitochondrial complex I deficiency in Parkinson's disease.

TL;DR: Results indicated a specific defect of Complex I activity in the substantia nigra of patients with Parkinson's disease, which adds further support to the proposition that Parkinson’s disease may be due to an environmental toxin with action(s) similar to those of MPTP.
Journal ArticleDOI

The ubiquitin-proteasome proteolytic pathway

TL;DR: Two studies clearly demonstrate that the ubiquitin-proteasome system is involved not only in complete destruction of its protein substrates, but also in limited proteolysis and posttranslational processing in which biologically active peptides or fragments are generated.
Related Papers (5)